Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02498613 |
|---|---|
| Brief Title: | A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors |
| First Submitted : | July 14, 2015 |
| First Submitted that Met QC Criteria : | July 14, 2015 |
| First Posted : | July 15, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 11, 2024 |
| Last Update Posted : | April 12, 2024 |